AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Aldevron, active in the custom development and manufacture of plasmid DNA, proteins and mRNA for the biotech industry, formed a long-term partnership for the supply of plasmid DNA that will enable AavantiBio to advance its platform of innovative gene transfer therapies.   Aldevron will provide plasmids for AavantiBio’s future gene therapy programs, including the company’s neuromuscula...